Global Multi-omics Market – Industry Trends and Forecast to 2031

Global Multi-omics Market, By Products & Services (Products {Instruments, Consumables}, Services), Type (Single-cell, Bulk), Platform (Genomics), Application (Cell Biology), End-use (Academic & Research Organizations)  – Industry Trends and Forecast to 2031.

Multi-omics Market Analysis and Size

One of the primary drivers is the continuous evolution and refinement of omics technologies. Advances in spatial genomics, transcriptomics, proteomics, metabolomics, and other omics disciplines contribute to the generation of vast and intricate datasets, providing researchers with a more comprehensive understanding of biological systems. Furthermore, the rising demand for personalized medicine and targeted therapies amplifies the market's expansion. All these aforementioned factors collectively contribute to the advancement of the market.                                

Data Bridge Market Research analyses that the Multi-omics Market which was USD 2.9 Billion in 2023, would rocket up to USD 10.36 Billion by 2031, and is expected to undergo a CAGR of 15.2% during the forecast period. This indicates that the market value. “Products” dominates the products and services segment of the Multi-omics Market due to the increasing adoption of multi-omics approaches in various research domains. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation

Market Definition

Multi-omics refers to an approach in biological research that integrates data from multiple omics disciplines. Omics disciplines include genomics, transcriptomics, proteomics, metabolomics, and other omics fields that aim to characterize and quantify the components of biological systems.              

Multi-omics Market Dynamics

Drivers

• Advancements in Omics Technologies

Technological advancements in omics technologies, including genomics, proteomics, metabolomics, transcriptomics, and epigenomics, have significantly expanded our understanding of biological systems at a molecular level. These advancements enable researchers to study complex biological processes comprehensively, providing insights into disease mechanisms, drug responses, and personalized medicine. The continuous improvement and integration of multi-omics approaches facilitate the generation of holistic datasets, driving demand for multi-omics solutions and propelling market growth.

• Growing Applications in Precision Medicine

Multi-omics approaches play a crucial role in precision medicine by enabling comprehensive characterization of individuals' genetic, molecular, and environmental profiles. By integrating data from multiple omics disciplines, researchers can identify biomarkers, therapeutic targets, and disease subtypes with greater accuracy and specificity. This enhances diagnostic capabilities, facilitates personalized treatment strategies, and improves patient outcomes. As precision medicine initiatives gain momentum worldwide, the demand for multi-omics technologies and services is driving market expansion.

• Rising Demand for Integrated Data Analysis Solutions

As multi-omics datasets become increasingly complex and voluminous, there is a growing demand for advanced bioinformatics and data analysis solutions capable of handling integrated omics data. Analyzing multi-omics datasets requires sophisticated algorithms, computational tools, and statistical methods to extract meaningful insights, identify biological patterns, and interpret omics interactions comprehensively. Integrated data analysis platforms that enable seamless integration, visualization, and interpretation of multi-omics data are essential for driving research discoveries and translational applications.

• Growing Investment in Healthcare Facilities

Surging focus on improving the condition of healthcare facilities and improving the overall healthcare infrastructure is another important factor fostering the growth of the market. The rising number of partnerships and strategic collaborations between the public and private players about funding and application of new and improved technology is further creating lucrative market opportunities.  

Opportunities

• Integration of Artificial Intelligence and Machine Learning

Integrating artificial intelligence (AI) and machine learning (ML) techniques presents significant opportunities for advancing multi-omics research and data analysis. AI/ML algorithms can process large-scale multi-omics datasets, identify complex patterns, and predict molecular interactions more efficiently than traditional methods. By leveraging AI/ML-driven approaches, researchers can uncover novel biomarkers, drug targets, and disease mechanisms, accelerating the development of personalized medicine and precision therapeutics.

• Expansion into Clinical Diagnostics and Healthcare

The adoption of multi-omics approaches in clinical diagnostics and healthcare presents lucrative opportunities for market players. Multi-omics technologies offer comprehensive insights into the molecular mechanisms underlying diseases, enabling more accurate diagnosis, prognosis, and treatment selection. Integrating multi-omics data with clinical information allows for personalized patient management strategies and targeted interventions.

Restraints/Challenges

• Complexity and Standardization Challenges

Multi-omics data generation, integration, and analysis involve complex workflows and methodologies, presenting challenges related to standardization, reproducibility, and data quality. Variability in experimental protocols, data formats, and analysis pipelines can hinder cross-study comparisons, validation efforts, and the interpretation of results. Achieving consensus on standardized protocols, quality control measures, and data-sharing practices is essential to address these challenges and enhance the reliability and reproducibility of multi-omics research.

• Data Integration and Interpretation Complexity

Integrating diverse omics datasets, such as genomics, transcriptomics, proteomics, and metabolomics, poses significant computational and analytical challenges. Multi-omics data integration requires sophisticated bioinformatics tools, statistical methods, and computational resources to extract meaningful insights, identify biological patterns, and infer causal relationships accurately. Data integration and interpretation complexity can be a barrier for researchers with limited bioinformatics expertise or access to computational infrastructure, limiting the adoption and utilization of multi-omics approaches.

• High Costs and Resource Intensiveness

Multi-omics research entails significant costs and resource requirements associated with data generation, analysis, and validation. Omics technologies often involve expensive instrumentation, reagents, and computational resources, which can be prohibitive for researchers with limited funding or access to specialized facilities. Moreover, multi-omics studies typically require interdisciplinary collaboration, involving experts from various fields such as biology, bioinformatics, statistics, and computational science, adding to the complexity and resource intensiveness of research endeavors.

• Ethical and Regulatory Considerations

The use of multi-omics technologies raises ethical and regulatory concerns related to data privacy, informed consent, and data sharing, particularly in the context of human subjects research. Safeguarding patient confidentiality, ensuring compliance with data protection regulations, and addressing ethical implications of multi-omics research are critical considerations for researchers, healthcare providers, and regulatory authorities. Striking a balance between promoting scientific innovation and protecting individual rights and privacy is essential to fostering trust, transparency, and responsible use of multi-omics technologies in research and clinical practice.

This global multi-omics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Multi-omics Market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In September 2023, 10x Genomics, Inc. announced the commercial availability of a new kit to expand the capabilities of its chromium single cell gene expression flex assay to include high throughput multi-omic cellular profiling. The new kit enables streamlined, multi-omic characterization of cell populations so that researchers can expand their options at a larger scale and detect simultaneous gene and protein expression. This strategy helped the company to expand its product offerings
• In February 2023, Becton, Dickinson, and Company launched a high-throughput single-cell multiomics platform, Rhapsody HT Xpress System, to expand the scope of scientific discovery. This new system enables scientists to isolate, barcode, and analyze single cells at a high sample throughput - up to eight times more cells than prior versions of BD single-cell analysers. This strategy is anticipated to help the company widen its product applications and cater to a larger customer base

Multi-omics Market Scope

The global multi-omics market is segmented on the basis of products & services, type, platform, application, and end-use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product & Services

• Products
  • Instruments
  • Consumables
  • Software
• Services

Type

• Single-cell multi-omics
• Bulk multi-omics

Platform

• Genomics
• Transcriptomics
• Proteomics
• Metabolomics
• Integrated omics platforms

Application

• Oncology
• Cell biology
• Neurology
• Immunology
• Other applications

End-use

• Academic and research organizations
• Pharmaceutical & biotechnology companies
• Hospital and diagnostic laboratories
• Other end-users

Multi-omics Market Regional Analysis/Insights

The global multi-omics market is analyzed and market size insights and trends are provided by country, products & services, type, platform, application & end-use as referenced above.

The countries covered in the global multi-omics market report are U.S., Canada, Mexico, U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Belgium, Turkey, Rest of Europe, China, Japan, India, Australia, South Korea, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Rest of South America, South Africa, and Rest of Middle East and Africa.

North America is expected to dominate the market due to high growth can be attributed to a confluence of factors, including substantial investments in research and development, a robust infrastructure for healthcare innovation, and a proactive regulatory environment fostering the adoption of multi-omics approaches.

Asia-Pacific is projected to observe a significant amount of growth in the market due to the rapid necessity for telemedicine and healthcare support. Moreover, the modernization and development in telecommunication is further anticipated to propel the market growth.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The global multi-omics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Multi-omics Market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Multi-omics Market. The data is available for historic period 2010-2020.

Competitive Landscape and Multi-omics Market Share Analysis

The global multi-omics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global multi-omics market.

Some of the major players operating in the multi-omics market are:

• Becton, Dickinson and Company (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• Illumina, Inc. (U.S.)
• Danaher (U.S.)
• PerkinElmer Inc. (U.S.)
• Shimadzu Corporation (Japan)
• Bruker (U.S.)
• QIAGEN (Germany)
• Agilent Technologies, Inc. (U.S.)
• BGI (China)
• 10x Genomics (U.S.)
• CYTENA GmbH (Germany)